Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 7—July 2008

Sudden Onset of Pseudotuberculosis in Humans, France, 2004–05

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Pascal Vincent*†‡1Comments to Author , Alexandre Leclercq§1Comments to Author , Liliane Martin§, Jean-Marie Duez¶, Michel Simonet*‡2, Elisabeth Carniel§2, and Yersinia Surveillance Network
Author affiliations: *Institut National de la Santé et de la Recherche Médicale (INSERM), Lille, France; †Université Lille 2, Lille; ‡Institut Pasteur de Lille, Lille; §Institut Pasteur, Paris, France; ¶Centre Hospitalier du Bocage, Dijon, France;

Cite This Article


Cases of Yersinia pseudotuberculosis infection increased in France during the winter of 2004–05 in the absence of epidemiologic links between patients or strains. This increase represents transient amplification of a pathogen endemic to the area and may be related to increased prevalence of the pathogen in rodent reservoirs.

Yersinia pseudotuberculosis is an enterobacterial pathogen able to grow at low temperatures. It is widespread in the environment (e.g., water, plants), which is the source of contamination for mammals (especially rodents and their predators) and birds (1,2). Although most cases of human infection are sporadic, outbreaks have occurred in Japan (3,4), Russia (5,6), and Finland (7,8), mainly associated with unchlorinated drinking water or contaminated vegetables. In France, similar increases in case numbers had not been noted until the winter of 2004–05.

The Study

In early January 2005, the French Yersinia National Reference Laboratory (YNRL) received 3 Y. pseudotuberculosis strains isolated by the same laboratory in Dijon over a 1-week period: 2 from fecal samples of 2 children attending the same daycare center and 1 from the blood of a 65-year-old woman. During the same month, 8 additional strains were isolated from persons in other parts of the country by the Yersinia Surveillance Network (based on voluntary participation of 88 hospital-based and private-sector medical laboratories throughout France).

In view of this unusually high number of Y. pseudotuberculosis isolations over a short period, the YNRL alerted France’s national disease surveillance network, the Institut de Veille Sanitaire, which thereafter performed an epidemiologic investigation. In early February, a request was mailed to all member laboratories in the Yersinia Surveillance Network and all 95 microbiology laboratories in university medical centers, asking them to report any recent cases of Y. pseudotuberculosis infection. A reminder letter was mailed to all laboratories that had not replied within 1 month of the initial communication. Moreover, from February through April 2005, a total of 76 general medical center laboratories were contacted by telephone and asked to provide the YNRL with any relevant information and/or isolates. Overall, 27 cases of culture-confirmed Y. pseudotuberculosis infections were spontaneously reported or actively retrieved (Table 1).

Figure 1

Thumbnail of Map of France, showing spatial distribution of Yersinia pseudotuberculosis infections during the winter of 2004–05. Black circles, patients' residences; open circles, cities with medical laboratories that stated that they had not isolated any Y. pseudotuberculosis from clinical specimens.

Figure 1. Map of France, showing spatial distribution of Yersinia pseudotuberculosis infections during the winter of 2004–05. Black circles, patients' residences; open circles, cities with medical laboratories that stated that they had not...

Case reports of Y. pseudotuberculosis infection peaked in January 2005. A food-exposure analysis for the first 10 patients did not identify a potential common food source, so a food survey was not performed for subsequent cases. The pseudotuberculosis cases occurred in 19 different counties throughout France, not necessarily the most populated ones (Figure 1). Data on lifestyle and living conditions were obtained for all but 7 patients, of whom 3 had died and 4 (including 2 children) were lost to follow-up. Of the 22 adults, 13 lived in small towns (<5,000 inhabitants) and 5 lived in rural villages (<500 inhabitants). All but 4 lived in houses, as opposed to apartments. Of the 17 adults whose lifestyle was investigated in detail, 14 had a dog, hunted, gardened, and/or grew their own vegetables. In contrast, all 5 children lived in urban areas (>50,000 inhabitants), compared with only 3 of the 22 adults; 4 of the children lived in apartments.

Of the 27 strains isolated, 25 were sent to the YNRL for characterization. All but 4 strains belonged to serotype I, the most common serotype in France. Pulsed-field gel electrophoresis after SpeI digestion of genomic DNA showed that (with the exception of the isolates from the 2 children attending the same daycare center) the DNA fingerprints of the 16 other isolates sent to the YNRL during the peak period were all distinct, even when the strains were isolated from the same county (data not shown).


This episode of increased case numbers differs from episodes reported in the literature by the nationwide distribution of cases, the absence of a locally defined cluster, the genetic diversity of the isolates, the predominance of rural residence for patients, and the dominant clinical presentation of septicemia (38). Because the cases were not related to the consumption of a food product sold nationally (e.g., by a supermarket chain), the unknown origin of this phenomenon raises the question of an emerging risk in a new epidemiologic situation.

Of the 27 patients, 19 lived in a strip of land that stretches from northern France to the Atlantic coast and corresponds to the flyways of small migratory birds. Hence, the avian introduction of strains into the country would have been a possible scenario, as has already been suspected for an epizootic of pseudotuberculosis in an American wildlife park (9). Indeed, during the winter of 2004–05, France witnessed a large and unexpected invasion of Bohemian waxwings (Bombycilla garrulus) (10), a species known to migrate from circumpolar areas where pseudotuberculosis is endemic. At that same time, 3 pseudotuberculosis outbreaks were reported in Siberia (11). However, the genetic diversity of the strains isolated from the patients in France and the absence of PCR amplification of the superantigen-encoding gene ypm gene (12) (which is highly prevalent in Far Eastern strains [1]) do not support bird-borne arrival in France of a Y. pseudotuberculosis clone from Russia or the Far East.

Figure 2

Thumbnail of County distribution, France, of Yersinia pseudotuberculosis isolated from human blood and reported to the Yersinia National Reference Laboratory over the 16 years preceding the winter of 2004–05. The number of isolates is represented by proportionally sized circles arbitrarily located at the center of the counties.

Figure 2. County distribution, France, of Yersinia pseudotuberculosis isolated from human blood and reported to the Yersinia National Reference Laboratory over the 16 years preceding the winter of 2004–05. The number of isolates...

These cases occurred in areas where other human cases of Y. pseudotuberculosis septicemia had been diagnosed (albeit at a much lower rate) in the past 16 years (Figure 2). Exacerbation of a preexisting epidemiologic situation is quite likely. Most previous cases of Y. pseudotuberculosis septicemia also concerned inhabitants of low-altitude plains (Figure 2), mainly in rural areas with extensive agriculture zones, which provide favorable habitats for small mammals. Cases were frequently (27.1%) reported in 5 central-western counties of France, where just 4.6% of the population live and incidence of Francisella tularensis infection (tularemia) is high (27.3%) ( Moreover, 40 cases of tularemia (with incidence peaks in summer and autumn) were reported to the national surveillance system in 2004 (notification of the disease has been obligatory since 2002), whereas only 8 to 19 cases per year had been reported over the preceding and following periods. Like Y. pseudotuberculosis, F. tularensis is known to have a rodent reservoir. Hence, the spatial and temporal correlations between human tularemia and pseudotuberculosis in France over recent years suggest the sudden expansion of a common reservoir in 2004.

Our analysis of the temporal distribution of human Y. pseudotuberculosis septicemia cases over the past 16 years showed a peak every 5 years (Table 2). This finding is reminiscent of human hantavirus infections, which have been linked to cyclical oscillations in the vole population (the virus reservoir). Taken as a whole, these data suggest that a rodent reservoir, mainly in rural areas, could have suddenly increased in the spring of 2004, thus increasing the risk for human transmission of Y. pseudotuberculosis and F. tularensis over the following months.

Rodent populations tend to increase with ongoing changes in agricultural practices, e.g., removal of farmland hedges (which provide shelter for the rodents’ predators) and reduction in pesticide use. Hence, the dynamics of the wild rodent population and reduction in pesticide use may represent a useful predictive marker for the occurrence of new outbreaks. The surveillance and control of the small mammal population might help limit the incidence of pseudotuberculosis and other wild rodent–borne diseases of humans in France.

Dr Vincent, a medical microbiologist at the Lille University Medical Center, is an associate member of the Institut National de la Santé et de la Recherche Médicale Unité 801 research group on the pathogenesis of Yersinia species. His main research interests are clinical microbiology and the epidemiology of infectious diseases.



We acknowledge the contributions of A. Goudeau, D. Poisson, L. Bret, R. Sanchez, H. Biessy, M. Weber, J.L. Fauchère, G. Chambreuil, P. Geslin, J.M. Seigneurin, G. Grise, J.C. Reveil, C. Auvray, and C. Recule. We also thank H. Porcheret, A. Secher, A. Marmonier, V. Sivadon, and F. Deyroys du Roure for sending the Y. pseudotuberculosis isolates to YNRL and/or for providing clinical information about patients. We also acknowledge the help of E. Espié and V. Vaillant for food exposure investigations and that of A. Mailles for obtaining national data on human tularemia.



  1. Fukushima  H, Matsuda  Y, Seki  R, Tsubokura  M, Takeda  N, Shubin  FN, Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J Clin Microbiol. 2001;39:35417. DOIPubMedGoogle Scholar
  2. Niskanen  T, Waldenstrom  J, Fredriksson-Ahomaa  M, Olsen  B, Korkeala  H. virF-positive Yersinia pseudotuberculosis and Yersinia enterocolitica found in migratory birds in Sweden. Appl Environ Microbiol. 2003;69:46705. DOIPubMedGoogle Scholar
  3. Inoue  M, Nakashima  H, Ishida  T, Tsubokura  M. Three outbreaks of Yersinia pseudotuberculosis infection. Zentralbl Bakteriol Mikrobiol Hyg [B]. 1988;186:50411.PubMedGoogle Scholar
  4. Nakano  T, Kawaguchi  H, Nakao  K, Maruyama  T, Kamiya  H, Sakurai  M. Two outbreaks of Yersinia pseudotuberculosis 5a infection in Japan. Scand J Infect Dis. 1989;21:1759. DOIPubMedGoogle Scholar
  5. Somov  GP, Martinevsky  IL. New facts about pseudotuberculosis in the USSR. On the outcome of the first conference on human pseudotuberculosis in the USSR. Contrib Microbiol Immunol. 1973;2:2146.
  6. Smirnova  YY, Tebekin  AB, Tseneva  GY, Rybakova  NA, Rybakov  DA. Epidemiological features of Yersinia infection in a territory with developed agricultural production. Epinorth 2004 [cited 2005 April 1]. Available from
  7. Jalava  K, Hallanvuo  S, Nakari  UM, Ruutu  P, Kela  E, Heinasmaki  T, Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland. J Clin Microbiol. 2004;42:278991. DOIPubMedGoogle Scholar
  8. Hallanvuo  S, Nuorti  P, Nakari  UM, Siitonen  A. Molecular epidemiology of the five recent outbreaks of Yersinia pseudotuberculosis in Finland. Adv Exp Med Biol. 2003;529:30912. DOIPubMedGoogle Scholar
  9. Welsh  RD, Ely  RW, Holland  RJ. Epizootic of Yersinia pseudotuberculosis in a wildlife park. J Am Vet Med Assoc. 1992;201:1424.PubMedGoogle Scholar
  10. Fouarge  J, Vandevondele  P. Synthesis on the exceptional invasion of waxwings (Bombycilla garrulus) in Europe in 2004–2005 [in French]. Aves. 2005;42:281311.
  11. Yersiniosis—Russia (Siberia). Promed. 2005 Apr 27. Available from, archive no: 20050427.1169.
  12. Carnoy  C, Floquet  S, Marceau  M, Sebbane  F, Haentjens-Herwegh  S, Devalckenaere  A, The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis. J Bacteriol. 2002;184:448999. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1407.071339

1These authors contributed equally to this article.

2These authors contributed equally to the supervision of this work.

Table of Contents – Volume 14, Number 7—July 2008

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Pascal Vincent, Service de Bactériologie-Hygiène, Centre de Biologie Pathologie/Centre Hospitalier Régional Universitaire de Lille, bd du Pr J. Leclercq, F-59 037 Lille CEDEX, France; Pascal Vincent, Service de Bactériologie-Hygiène, Centre de Biologie Pathologie/Centre Hospitalier Régional Universitaire de Lille, bd du Pr J. Leclercq, F-59 037 Lille CEDEX, France;

Send To

10000 character(s) remaining.


Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.